EP0580846A1 - Composite material having a lubricous surface for catheter use - Google Patents

Composite material having a lubricous surface for catheter use

Info

Publication number
EP0580846A1
EP0580846A1 EP93905020A EP93905020A EP0580846A1 EP 0580846 A1 EP0580846 A1 EP 0580846A1 EP 93905020 A EP93905020 A EP 93905020A EP 93905020 A EP93905020 A EP 93905020A EP 0580846 A1 EP0580846 A1 EP 0580846A1
Authority
EP
European Patent Office
Prior art keywords
lubricous
catheter
particulate
dilatation
dilatation catheter
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP93905020A
Other languages
German (de)
French (fr)
Other versions
EP0580846A4 (en
Inventor
Tai Chun Cheng
Douglas C. Harrington
Robert D. Ainsworth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Cardiovascular Systems Inc
Original Assignee
Advanced Cardiovascular Systems Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Cardiovascular Systems Inc filed Critical Advanced Cardiovascular Systems Inc
Publication of EP0580846A1 publication Critical patent/EP0580846A1/en
Publication of EP0580846A4 publication Critical patent/EP0580846A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/10Balloon catheters
    • A61M25/104Balloon catheters used for angioplasty
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/0043Catheters; Hollow probes characterised by structural features
    • A61M25/0045Catheters; Hollow probes characterised by structural features multi-layered, e.g. coated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/10Balloon catheters
    • A61M2025/1043Balloon catheters with special features or adapted for special applications
    • A61M2025/1079Balloon catheters with special features or adapted for special applications having radio-opaque markers in the region of the balloon

Definitions

  • This invention generally relates to intraluminal catheters, such as guiding catheters and balloon dilatation catheters used in percutaneous transluminal coronary angioplasty PTCA).
  • a guiding catheter having a preshaped distal tip is percutaneously introduced by a Seldinger technique into the cardiovascular system of a patient and advanced therein until the preshaped distal tip of the guiding catheter is disposed within the aorta adjacent the ostium of the desired coronary artery.
  • the guiding catheter is twisted or torqued from the proximal end to turn the distal tip of the
  • a guidewire and a balloon dilatation catheter are introduced into and advanced through the guiding catheter to the distal tip thereof, with the guidewire slidably disposed within an inner lumen of the dilatation catheter.
  • the guidewire is first advanced out the distal tip of the guiding catheter, which is seated in the ostium of the patient's coronary artery, until the distal end of the guidewire crosses the lesion to be dilated.
  • the dilatation catheter is then advanced out of the distal tip of the guiding catheter, over the previously advanced guidewire, until the balloon on the distal extremity of the dilatation catheter is properly positioned across the lesion.
  • the balloon is inflated to a predetermined size with radiopaque liquid at relatively high pressures (e.g., generally 4-12 atmospheres) to dilate the stenosed region of the diseased artery.
  • relatively high pressures e.g., generally 4-12 atmospheres
  • One or more inflations may be necessary to effectively dilate the stenosis.
  • Additional stenoses may be dilatated with the same catheter.
  • the balloon is deflated so that the dilatation catheter can be removed from the dilated stenosis and blood flow will resume through the dilated artery.
  • the fixed-wire dilatation catheters generally have an outer tubular member with an inflatable balloon on the distal section thereof which is capable of dilating a stenosis, and a guiding member extending out through the distal end of the balloon which aids in advancing the catheter to a desired location within the patient's vasculature. They also usually have no inner tubular member and therefore have lower profiles, e.g. transverse dimensions, than over-the-wire dilatation catheters having the same inflated balloon size.
  • the fixed-wire catheters have the guidewire or guiding member fixed or at least restricted as to longitudinal movement, these catheters generally have greater pushability than over-the-wire type catheters such as described and claimed in U.S. Patent 4,323,071 (Simpson-Robert).
  • the lower profile and greater pushability of the fixed-wire dilatation catheters allows them to cross tighter lesions and to be advanced much deeper into a patient's coronary anatomy than the over-the-wire dilatation catheters of comparable sizes.
  • the rapid exchange type dilatation catheter has a short guidewire receiving sleeve or inner lumen extending through the flexible distal portion of the catheter which extends out of the guiding catheter into the patient's coronary artery during the angioplasty procedure.
  • the sleeve extends proximally a distance of at least 10 cm and usually not more than about 50 cm from a first guidewire port in the distal end of the catheter to a second guidewire port in the catheter spaced proximally from the inflatable balloon of the catheter.
  • a slit as described in Horzewski et al, is preferably provided in the catheter wall which extends distally from the second guidewire port, preferably to a location proximal to the proximal end of the inflatable balloon to aid in the removal of the catheter from a guidewire.
  • the structure of the catheter allows for the rapid exchange of the catheter without the need for the use of an exchange wire or adding a guidewire extension to the proximal end of the guidewire.
  • the design of this catheter is described in Horzewski et al.
  • DILATATION CATHETER DILATATION CATHETER, and which are incorporated herein by reference.
  • perfusion ports are provided in the catheter shaft, proximal and distal to the balloon, which are in fluid communication with the guidewire receiving inner lumen to allow blood to perfuse distal to the catheter when the balloon is inflated.
  • the present invention is directed to an improved composite plastic material having a very durable lubricous surface and particularly to tubular products for intraluminal catheter procedures within a human patient made from such composite materials.
  • the material of the invention generally includes a
  • biocompatible polymer matrix having finely divided lubricous particulate matter incorporated within the matrix.
  • the polymer matrix can be formed of thermoplastic or thermosetting materials, or mixtures thereof.
  • thermoplastic materials particularly thermoplastic polymers having substantial crystallinity such as polyethylene, are preferred when the final product has a tubular shape because thermoplastic resins can be more easily extruded or otherwise formed in a conventional fashion.
  • the lubricous particulate is well dispersed within the polymer matrix the extrusion pressure or other forces needed to form the product are significantly lowered and there is much better dimensional control during the extrusion process than the same plastic materials without the lubricous particulate matter incorporated therein.
  • Increased strengths in addition to decreased frictional characteristics are also obtained by the incorporation of the lubricous particulate.
  • the coefficient of friction of this material ranges from about 0.03 to about 0.20.
  • the tubular products of the invention can be formed into the shafts or inflatable members, e.g. balloons, of intraluminal catheters such as balloon dilatation catheters for angioplasty procedures in a conventional manner. Both the shafts and the balloons exhibit the same improvements in lubricity and strength with the materials of the invention.
  • Fig. 1 is an elevational view, partially in section of a balloon dilatation catheter embodying features of the invention.
  • Fig. 2 is a transverse cross-sectional view of the catheter shown in Fig. 1 taken along the lines 2-2.
  • Fig. 3 is a transverse cross-sectional view of the catheter shown in Fig. 1 taken along the lines 3-3.
  • Figs. 1-3 illustrate a balloon dilatation catheter which embodies features of the invention.
  • the dilatation catheter generally includes an outer tubular member 10, a dilatation balloon 11 on the distal
  • a guidewire 15 is slidably disposed within the inner lumen 16 of the inner tubular member 12.
  • the distal end of the catheter is provided with a self venting means such as described in U.S. Patent 4,638,805 (Powell).
  • a radiopaque marker 17 is disposed about the inner tubular member 12 at the mid-point of the balloon 11 to facilitate the fluoroscopic observation thereof during an angioplasty procedure.
  • the brachial marker 20 and femoral marker 21 are provided on the proximal end of the inner tubular member 12.
  • the inner tubular member 12 is formed of composite material which generally includes a polymer matrix, preferably a readily extrudable thermoplastic polymer and incorporated within the polymer matrix is a finely divided lubricous particulate matter which range on the average from about 0.1 to about 100 microns, preferably about 0.5 to about 20 microns, in maximum dimensions.
  • the amount of particulate matter in the polymer matrix thereof may range from about 0.5 to about 50%, preferably about 2 to about 20%, of the precured mixture thereof. As used herein all percentages are weight percent unless noted otherwise.
  • a dispersing agent such as lecithin, silicone oil, vegetable oil, polyethylene wax or mixtures thereof, may be incorporated into the mixture to facilitate effective mixing of the particulate within the polymer resin.
  • a dispersing agent such as lecithin, silicone oil, vegetable oil, polyethylene wax or mixtures thereof.
  • Particularly suitable lubricous particulate materials include graphite, fluoropolymers such as Teflon ® , molybdenum disulfide, titanium carbide, molybdenum carbide, graphite difluoride or mixtures thereof.
  • Presently preferred lubricous particulate include Micro 850 and Micro 250 graphite available from the Asbury Graphite Mills, located in Asbury County, New Jersey. This graphite has an average maximum particle size from about 3 to about 10 microns in maximum dimension.
  • silicone oils such as dimethylsiloxane polymers with a viscosity between about 300 and 100,000 centipoise, preferably about 1000 to about 30,000 centipoise, can be incorporated along with the solid lubricous particulate in
  • Suitable polymer materials include thermoplastic and thermosetting polymers or mixtures thereof, although thermoplastic polymer resins are preferred because of their ease in manufacturing tubular and other products by extruding and other types of pressure forming.
  • Polymer materials such as polyethylene, polypropylene, polyvinyl chloride, polyethylene terephthalate, polyesters (e.g. nylon) and ionomers (e.g. Surlyn ® such as 8020 sold by E.I. duPont, deNemours & Co.) are particularly suitable. Blends of such materials may also be used.
  • Formation of the products of the invention typically involve intimately mixing the lubricous particulate into the uncured polymer resin which forms the matrix of the cured product.
  • a dispersant may be first mixed with the lubricous particulate to facilitate a more uniform dispersement of the particulate throughout the uncured resin.
  • the dispersant may be advantageously added to the lubricous particulate as a solution of isopropyl alcohol or other suitable solvent to facilitate the incorporation thereof.
  • the finely divided lubricous particulate has a tendency to agglomerate and an intimate and uniform mixture of the particulate within the polymer matrix can be very difficult to obtain without a dispersant.
  • the polymer-parti cul ate mixture is then preferably extruded in
  • the tubular product is then cured.
  • the polymer matrix is a thermoplastic material such as polyethylene
  • the extruded product may be cross-linked or modified by a conventional radiation treatment with gamma radiation or peroxide or other inorganic catalysts. Radiation levels of about 2 to about 150 //rads has been found to be suitable. After curing the tubing may be cut to the desired length depending upon the ultimate end use thereof.
  • the distal portion of the tubular product is disposed within the interior of a hollow mold, which has the desired shape of the inflatable member to be made, and then the interior of the distal portion of the tubular product is subjected to heat and pressurized fluid to expand the distal section within the mold to form the inflatable member of the desired size and shape.
  • a 4000 gram mixture was prepared containing 3830 grams (95.75%) of high density
  • the composite material of the invention can be utilized in a wide variety intraluminal catheter components.
  • the material can be used to form the outer tubular member in an over-the- wire dilatation catheter or a fixed-wire dilatation catheter. All or a portion of the outer tubular member may be formed of the polymer matrix-fmely divided lubricous particulate. The material can also be used to form the inflatable member or balloon of a dilatation catheter.
  • Guidewire receiving inner tubular members such as described in the Yock and Horzewski et al.
  • patents which have been incorporated herein, may be made of the composite material formed of polymer and low friction particulate. Another use is the formation of guiding catheters in which the composite material is used to form at least the inner liner of the catheter to provide the lubricous inner lumen required in this type of intravascular catheter. Other uses include shafts and inflatable members of urethral dilatation catheters and Foley type catheters.

Abstract

Un composant pour cathéter (10) intravasculaire à faible friction est constitué d'une matrice polymère englobant une matière à fines particules anti-friction. Cette matrice se compose de préférence d'un polymère thermoplastique et la matière à particule anti-friction appropriée comprend graphite, bisulfure de molybdène, TiC, MoC, difluorure de graphite et des fluoropolymères. Les composants typiquement réalisés avec cette matière à faible friction sont notamment les sections tubulaires internes (12) ou externes (14) de cathéters de dilatation (10) à guide fixe ou coulissant. On peut incorporer un fluide à base de polysiloxane à cette matrice en plus de la matière à particules anti-friction.A component for a low friction intravascular catheter (10) consists of a polymer matrix including a material with fine anti-friction particles. This matrix preferably consists of a thermoplastic polymer and the suitable anti-friction particle material includes graphite, molybdenum disulfide, TiC, MoC, graphite difluoride and fluoropolymers. The components typically produced with this low friction material are notably the internal (12) or external (14) tubular sections of dilation catheters (10) with fixed or sliding guide. A polysiloxane-based fluid can be incorporated into this matrix in addition to the material with anti-friction particles.

Description

COMPOSITE MATERIAL HAVING A LUBRICOUS SURFACE
FOR CATHETER USE
BACKGROUND OF THE INVENTION
This invention generally relates to intraluminal catheters, such as guiding catheters and balloon dilatation catheters used in percutaneous transluminal coronary angioplasty PTCA).
In classic PTCA procedures, a guiding catheter having a preshaped distal tip is percutaneously introduced by a Seldinger technique into the cardiovascular system of a patient and advanced therein until the preshaped distal tip of the guiding catheter is disposed within the aorta adjacent the ostium of the desired coronary artery. The guiding catheter is twisted or torqued from the proximal end to turn the distal tip of the
- 1 - guiding catheter so that it can be guided into the desired coronary ostium. In over-the-wire systems, a guidewire and a balloon dilatation catheter are introduced into and advanced through the guiding catheter to the distal tip thereof, with the guidewire slidably disposed within an inner lumen of the dilatation catheter. The guidewire is first advanced out the distal tip of the guiding catheter, which is seated in the ostium of the patient's coronary artery, until the distal end of the guidewire crosses the lesion to be dilated. The dilatation catheter is then advanced out of the distal tip of the guiding catheter, over the previously advanced guidewire, until the balloon on the distal extremity of the dilatation catheter is properly positioned across the lesion. Once properly positioned, the balloon is inflated to a predetermined size with radiopaque liquid at relatively high pressures (e.g., generally 4-12 atmospheres) to dilate the stenosed region of the diseased artery. One or more inflations may be necessary to effectively dilate the stenosis. Additional stenoses may be dilatated with the same catheter. When the dilatations are completed, the balloon is deflated so that the dilatation catheter can be removed from the dilated stenosis and blood flow will resume through the dilated artery.
Further details of guiding catheters, dilatation catheters, guidewires, and other devices for angioplasty procedures can be found in U.S. Patent 4,323,071 (Simpson-Robert); U.S. Patent 4,439,185 (Lundquist); U.S. Patent 4,468,224 (Enzmann et al); U.S. Patent 4,516,972 (Samson); U.S. Patent 4,438,622 (Samson et al); U.S. Patent 4,554,929 (Samson et
al); U.S. Patent 4,582,185 (Samson); U.S. Patent 4,616,652 (Simpson); U.S. Patent 4,638,805 (Powell); U.S. Patent 4,748,986 (Morrison et al); U.S. Patent 4,898,577 (Badger et al); and U.S.Patent 4,827,943 (Taylor et al.) which are incorporated herein in their entirety by reference thereto.
Fixed-wire dilatation catheters for coronary angioplasty, which were first described in U. S. Patent 4,252,181 (Samson) now Reissue patent 33,166, are similarly used except there is no longitudinal movement between the guidewire and the catheter. The fixed-wire dilatation catheters generally have an outer tubular member with an inflatable balloon on the distal section thereof which is capable of dilating a stenosis, and a guiding member extending out through the distal end of the balloon which aids in advancing the catheter to a desired location within the patient's vasculature. They also usually have no inner tubular member and therefore have lower profiles, e.g. transverse dimensions, than over-the-wire dilatation catheters having the same inflated balloon size. Moreover, because the fixed-wire catheters have the guidewire or guiding member fixed or at least restricted as to longitudinal movement, these catheters generally have greater pushability than over-the-wire type catheters such as described and claimed in U.S. Patent 4,323,071 (Simpson-Robert). The lower profile and greater pushability of the fixed-wire dilatation catheters allows them to cross tighter lesions and to be advanced much deeper into a patient's coronary anatomy than the over-the-wire dilatation catheters of comparable sizes.
Various improvements have been made to intravascular catheters used in angioplasty and other intravascular procedures. Of particular note is a rapid exchange type catheters described and claimed in U.S. Patent 5,040,548 (Yock), U.S. Patent 5,061,273 (Yock), and U.S. Patent 4,748,982 (Horzewski et al), which are incorporated herein in their entirety by reference. The rapid exchange type dilatation catheter has a short guidewire receiving sleeve or inner lumen extending through the flexible distal portion of the catheter which extends out of the guiding catheter into the patient's coronary artery during the angioplasty procedure. The sleeve extends proximally a distance of at least 10 cm and usually not more than about 50 cm from a first guidewire port in the distal end of the catheter to a second guidewire port in the catheter spaced proximally from the inflatable balloon of the catheter. A slit, as described in Horzewski et al, is preferably provided in the catheter wall which extends distally from the second guidewire port, preferably to a location proximal to the proximal end of the inflatable balloon to aid in the removal of the catheter from a guidewire. The structure of the catheter allows for the rapid exchange of the catheter without the need for the use of an exchange wire or adding a guidewire extension to the proximal end of the guidewire. The design of this catheter
has been widely praised by the medical profession and has met with much commercial success in the market place because of its unique design.
A substantial improvement in the rapid exchange type dilatation catheters, such as described above, has recently been made by Mclnnes et al. which is described in copending applications Serial No. 07/476,056, filed February 7, 1990 and Serial No. 07/541,264 filed June 19, 1990, both entitled READILY EXCHANGEABLE PERFUSION
DILATATION CATHETER, and which are incorporated herein by reference. In these rapid exchange type dilatation catheters, perfusion ports are provided in the catheter shaft, proximal and distal to the balloon, which are in fluid communication with the guidewire receiving inner lumen to allow blood to perfuse distal to the catheter when the balloon is inflated.
Lubricous coatings have been applied to the surfaces of guiding catheters, dilatation catheters and other intraluminal catheters in order to reduce the friction between the surfaces of these catheters and other components of the catheter systems in which the catheters are employed during the intravascular procedures. For example, fluoropolymer linings such as Teflon® are very frequently employed as the inner linings of guiding catheters in order to reduce the friction between the inner lining of the guiding catheter and the guidewire and the catheters which might be advanced through the inner lumen of the guiding catheter. Lubricous silicone coatings have been applied to the surfaces of guidewires and of dilatation catheters to likewise reduce the frictional characteristics of these devices. However, the application of these lubricous coatings and linings are for the most part complicated manufacturing processes. Moreover, very frequently these coatings and linings are not very durable and lose substantial portions of their lubricity during the intraluminal or intravascular procedure.
What has been needed and heretofore unavailable is a durable high strength plastic surface having long lasting lubricity which does not require complicated manufacturing procedures. The present invention satisfies this and other needs.
SUMMARY OF THE INVENTION
The present invention is directed to an improved composite plastic material having a very durable lubricous surface and particularly to tubular products for intraluminal catheter procedures within a human patient made from such composite materials. The material of the invention generally includes a
biocompatible polymer matrix having finely divided lubricous particulate matter incorporated within the matrix.
The polymer matrix can be formed of thermoplastic or thermosetting materials, or mixtures thereof. However, thermoplastic materials, particularly thermoplastic polymers having substantial crystallinity such as polyethylene, are preferred when the final product has a tubular shape because thermoplastic resins can be more easily extruded or otherwise formed in a conventional fashion. When the lubricous particulate is well dispersed within the polymer matrix the extrusion pressure or other forces needed to form the product are significantly lowered and there is much better dimensional control during the extrusion process than the same plastic materials without the lubricous particulate matter incorporated therein. Increased strengths in addition to decreased frictional characteristics are also obtained by the incorporation of the lubricous particulate. The coefficient of friction of this material ranges from about 0.03 to about 0.20.
The tubular products of the invention can be formed into the shafts or inflatable members, e.g. balloons, of intraluminal catheters such as balloon dilatation catheters for angioplasty procedures in a conventional manner. Both the shafts and the balloons exhibit the same improvements in lubricity and strength with the materials of the invention.
These and other advantages of the invention will become more apparent from the following detailed description of the invention when taken in conjunction with the accompanying exemplary drawings.
BRIEF DESCRIPTION OF THE DRAWINGS
Fig. 1 is an elevational view, partially in section of a balloon dilatation catheter embodying features of the invention.
Fig. 2 is a transverse cross-sectional view of the catheter shown in Fig. 1 taken along the lines 2-2.
Fig. 3 is a transverse cross-sectional view of the catheter shown in Fig. 1 taken along the lines 3-3.
DETAILED DESCRIPTION OF THE INVENTION
Figs. 1-3 illustrate a balloon dilatation catheter which embodies features of the invention. The dilatation catheter generally includes an outer tubular member 10, a dilatation balloon 11 on the distal
portion of the outer tubular member, an inner member 12 disposed within the outer tubular member and the balloon and a multi-arm adapter 13 mounted on the proximal ends of the inner and outer tubular members. The distal end of the balloon 11 is sealed about the distal end of the inner tubular member 12 so that injection of inflation fluid under significant pressure through annular lumen 14 to the interior of the balloon will result in the inflation thereof. A guidewire 15 is slidably disposed within the inner lumen 16 of the inner tubular member 12. The distal end of the catheter is provided with a self venting means such as described in U.S. Patent 4,638,805 (Powell).
A radiopaque marker 17 is disposed about the inner tubular member 12 at the mid-point of the balloon 11 to facilitate the fluoroscopic observation thereof during an angioplasty procedure. The brachial marker 20 and femoral marker 21 are provided on the proximal end of the inner tubular member 12.
In accordance with the invention, the inner tubular member 12 is formed of composite material which generally includes a polymer matrix, preferably a readily extrudable thermoplastic polymer and incorporated within the polymer matrix is a finely divided lubricous particulate matter which range on the average from about 0.1 to about 100 microns, preferably about 0.5 to about 20 microns, in maximum dimensions. The amount of particulate matter in the polymer matrix thereof may range from about 0.5 to about 50%, preferably about 2 to about 20%, of the precured mixture thereof. As used herein all percentages are weight percent unless noted otherwise. Up to about 1% of a dispersing agent, such as lecithin, silicone oil, vegetable oil, polyethylene wax or mixtures thereof, may be incorporated into the mixture to facilitate effective mixing of the particulate within the polymer resin. A commercially available cooking oil described at least in part in U.S. Patent 4,188,412 and sold under the trademark PAM£ by Boyle-Midway Products, Inc., New York, New York, has been found to be particularly suitable.
Particularly suitable lubricous particulate materials include graphite, fluoropolymers such as Teflon®, molybdenum disulfide, titanium carbide, molybdenum carbide, graphite difluoride or mixtures thereof. Presently preferred lubricous particulate include Micro 850 and Micro 250 graphite available from the Asbury Graphite Mills, located in Asbury County, New Jersey. This graphite has an average maximum particle size from about 3 to about 10 microns in maximum dimension. In addition, silicone oils such as dimethylsiloxane polymers with a viscosity between about 300 and 100,000 centipoise, preferably about 1000 to about 30,000 centipoise, can be incorporated along with the solid lubricous particulate in
amounts of up to 10%, preferably about 0.5 to about 4%.
Suitable polymer materials include thermoplastic and thermosetting polymers or mixtures thereof, although thermoplastic polymer resins are preferred because of their ease in manufacturing tubular and other products by extruding and other types of pressure forming. Polymer materials such as polyethylene, polypropylene, polyvinyl chloride, polyethylene terephthalate, polyesters (e.g. nylon) and ionomers (e.g. Surlyn® such as 8020 sold by E.I. duPont, deNemours & Co.) are particularly suitable. Blends of such materials may also be used.
Formation of the products of the invention typically involve intimately mixing the lubricous particulate into the uncured polymer resin which forms the matrix of the cured product. A dispersant may be first mixed with the lubricous particulate to facilitate a more uniform dispersement of the particulate throughout the uncured resin. The dispersant may be advantageously added to the lubricous particulate as a solution of isopropyl alcohol or other suitable solvent to facilitate the incorporation thereof. The finely divided lubricous particulate has a tendency to agglomerate and an intimate and uniform mixture of the particulate within the polymer matrix can be very difficult to obtain without a dispersant.
The polymer-parti cul ate mixture is then preferably extruded in
a conventional manner into a tubular product having the desired dimensions. After extruding, the tubular product is then cured. If the polymer matrix is a thermoplastic material such as polyethylene, the extruded product may be cross-linked or modified by a conventional radiation treatment with gamma radiation or peroxide or other inorganic catalysts. Radiation levels of about 2 to about 150 //rads has been found to be suitable. After curing the tubing may be cut to the desired length depending upon the ultimate end use thereof.
If the tubular product is to be used to form an inflatable member (e.g. a balloon) for an angioplasty catheter such as element 12 shown in the drawings, the distal portion of the tubular product is disposed within the interior of a hollow mold, which has the desired shape of the inflatable member to be made, and then the interior of the distal portion of the tubular product is subjected to heat and pressurized fluid to expand the distal section within the mold to form the inflatable member of the desired size and shape. To illustrate a presently preferred embodiment, a 4000 gram mixture was prepared containing 3830 grams (95.75%) of high density
polyethylene, 160 grams (4%) of Micro 250 graphite and 10 grams (0.25%) of lecithin. The lecithin was first dissolved in 200 ml of isopropyl alcohol and then mixed with the graphite to form a homogeneous mass. The graphite with dispersant was then mixed with the polyethylene in a stainless steel tumbler for 16 hours and then extruded into pellets of about 5-6 mm. The pellets were extruded into a tubular product having nominal inner and outer diameters of about 0.019 and 0.0256 inch (0.48-0.65 mm), respectively, and the extruded tubular member was irradiated with gamma radiation at a level of about 10 μrads. The tubular member was then cut to length and used in the manufacture of a prototype dilatation catheter as shown in Figs. 1-3. The tubular member had a coefficient of friction of about 0.1.
While the invention has been described herein primarily in terms of an inner tubular member for an over-the-wire type dilatation catheter of concentric design, the composite material of the invention can be utilized in a wide variety intraluminal catheter components. For example, the material can be used to form the outer tubular member in an over-the- wire dilatation catheter or a fixed-wire dilatation catheter. All or a portion of the outer tubular member may be formed of the polymer matrix-fmely divided lubricous particulate. The material can also be used to form the inflatable member or balloon of a dilatation catheter. Guidewire receiving inner tubular members such as described in the Yock and Horzewski et al. patents, which have been incorporated herein, may be made of the composite material formed of polymer and low friction particulate. Another use is the formation of guiding catheters in which the composite material is used to form at least the inner liner of the catheter to provide the lubricous inner lumen required in this type of intravascular catheter. Other uses include shafts and inflatable members of urethral dilatation catheters and Foley type catheters.
While the invention is described herein in terms of certain presently preferred embodiments, those skilled in the art will recognize that various changes and improvements can be made to the present invention without departing from the scope thereof.

Claims

WHAT IS CLAIMED IS: 1. A dilatation catheter comprising:
a) an elongated catheter shaft which is formed at least in part of a first tubular member having a lubricous surface comprising a thermoplastic polymer matrix and finely divided solid lubricous particulate material dispersed within the matrix which defines a guidewire receiving inner lumen extending within the first tubular member; and b) an inflatable member on a distal portion of the elongated catheter shaft having an interior in fluid communication with an inner inflation lumen extending within the catheter shaft.
2. The dilatation catheter of claim 1 wherein the catheter shaft has a second tubular member disposed about the first tubular member and defining with the first tubular member the inner inflation lumen.
3. The dilatation catheter of claim 2 wherein the second tubular member has an inflatable element formed in a distal extremity thereof which has an interior in fluid communication with the inner inflation lumen.
4. The dilatation catheter of claim 1 wherein the solid lubricous particulate material is selected from the group consisting of graphite, molybdenum disulfide, TiC, MoC, graphite difluoride, fluoropolymers and mixtures thereof.
5. The dilatation catheter of claim 1 wherein the lubricous particulate material has an average particle size of about 0.1 to about 100 microns in maximum dimension.
6. The dilatation catheter of claim 1 wherein the lubricous particulate has an average particle size of about 0.5 to about 20 microns in maximum dimension.
7. The dilatation catheter of claim 1 wherein the amount of lubricous particulate matter ranges from about 0.5 to about 50% of the composite material.
8. The dilatation catheter of claim 1 wherein the amount of lubricous particulate matter ranges from about 1 to about 25% of the lubricous surface.
9. The dilatation catheter of claim 1 wherein the lubricous surface is formed from a mixture of thermoplastic polymer, solid lubricous particulate matter and from about 0.01 to about 5% of a dispersing agent.
10. The dilatation catheter of claim 1 wherein the lubricous surface is formed from a mixture of polymer, lubricous particulate matter and from about 0.05 to about 1% of a dispersing agent.
11. The dilatation catheter of claim 10 wherein the dispersing agent is selected from the group consisting of lecithin, silicone oil, vegetable oil, polyethylene wax and mixtures thereof.
12. A dilatation catheter comprising: a) an elongated catheter shaft which has a surface which is formed at least in part of a composite material including a thermoplastic polymer matrix and finely divided, solid lubricous particulate material dispersed within the polymer matrix; and b) an inflatable member on a distal portion of the elongated catheter shaft having an interior in fluid communication with an inner lumen extending within the catheter shaft.
13. The dilatation catheter of claim 12 wherein the catheter shaft is a tubular element formed of the composite material and has a guiding element extending at least through a portion of the inflatable member.
14. The dilatation catheter of claim 12 wherein the inflatable member is formed of the composite material. 15. The dilatation catheter of claim 1
- 1' wherein the plastic matrix is formed of a biocompatible polymer material.
15. The dilatation catheter of claim 1 wherein the plastic matrix is formed of a biocompatible polymer material.
16. The dilatation catheter of claim 1 including a silicone oil incorporated within the matrix.
17. The composite material of claim 1 having a coefficient of friction from about 0.03 to about 0.2.
18. A method for making a component for an intravascular catheter having a durable lubricous coating thereon comprising: a) mixing a biocompatible polymer resin with lubricous particulate; b) forming the resin-particulate mixture into a desired shape for the component; and c) curing the resin-particulate in the desired shape to form the component.
19. The method of claim 18 wherein the resin-particulate mixture is formed into a desired shape by extruding the mixture.
20. The method of claim 18 wherein the formed resin-particulate mixture
is cured by radiation.
21. The method of claim 18 wherein the desired shape is a hollow tube.
22. The method of claim 21 including the step of applying internal fluid pressure within the hollow tube with a portion of said tube disposed within the interior of a hollow mold at sufficient pressure and temperature to cause the portion of the tube within the mold to expand therein and take the shape of the interior thereof.
23. The method of claim 18 wherein the polymer resin is a thermoplastic resin.
24. The method of claim 18 wherein the lubricous particulate is selected from the group consisting of graphite, molybdenum disulfide, TiC, MoC, graphite difluoride, fluoropolymers and mixtures thereof.
25. The method of claim 24 wherein the lubricous particulate material has an average particle size of about 0.1 to about 100 microns in maximum dimension.
26. The method of claim 24 wherein the lubricous particulate material has a particle size of about 0.5 to about 20 microns in maximum dimension.
27. The method of claim 24 wherein the amount of lubricous particulate matter ranges from about 0.5 to about 50%.
28. The method of claim 24 wherein the amount of lubricous particulate matter ranges from about 1 to about 25%.
29. The method of claim 24 wherein from about 0.05 to about 1% of a dispersing agent is mixed with the polymer and lubricous particulate matter.
30. The method of claim 24 wherein the dispersing agent is selected from the group consisting of lecithin, silicone oil, vegetable oil, polyethylene wax and mixtures thereof.
31. An intravascular catheter comprising an elongated extruded tubular element having a lubricous surface formed of a thermoplastic polymer matrix and finely divided solid lubricous particulate material well dispersed within the matrix.
32. The intravascular catheter of claim 31 having a second tubular
member with an inner lumen extending therein with the extruded tubular element having a lubricous surface is disposed within the inner lumen of the second tubular member.
33. The intravascular catheter of claim 31 wherein the extruded tubular element is an outer tubular member and has formed therein an inflatable element.
34. The intravascular catheter of claim 31 wherein the lubricous particulate material is selected from the group consisting of graphite, molybdenum disulfide, TiC, MoC, graphite difluoride, fluoropolymers and mixtures thereof.
35. The intravascular catheter of claim 31 wherein the lubricous particulate material has an average particle size of about 0.1 to about 100 microns in maximum dimension.
36. The intravascular catheter of claim 31 wherein the lubricous particulate has an average particle size of about 0.5 to about 20 microns in maximum dimension.
37. The intravascular catheter of claim 31 wherein the amount of lubricous particulate matter ranges from about 0.5 to about 50%.
38. The intravascular catheter of claim 31 wherein the amount of lubricous particulate matter ranges from about 1 to about 25%.
39. The intravascular catheter of claim 31 formed from a mixture of polymer, lubricous particulate matter and from about 0.01 to about 5% of a dispersing agent.
40. The intravascular catheter of claim 31 formed from a mixture of polymer, lubricous particulate matter and from about 0.05 to about 1% of a dispersing agent.
41. The intravascular catheter of claim 33 wherein the dispersing agent is selected from the group consisting of lecithin, silicone oil, vegetable oil, polyethylene wax and mixtures thereof.
42. The intravascular catheter of claim 31 wherein the tubular element having a lubricous surface defines a short guidewire receiving inner lumen of a readily exchangeable dilatation catheter.
43. The intravascular catheter of claim 31 wherein the tubular element having a lubricous surface is an outer tubular element of a fixed-wire dilatation catheter.
44. The intravascular catheter of claim 31 wherein the tubular element having a lubricous surface has an inflatable member formed therein.
EP9393905020A 1992-02-10 1993-02-08 Composite material having a lubricous surface for catheter use Withdrawn EP0580846A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US83336992A 1992-02-10 1992-02-10
US833369 1997-04-04

Publications (2)

Publication Number Publication Date
EP0580846A1 true EP0580846A1 (en) 1994-02-02
EP0580846A4 EP0580846A4 (en) 1994-08-24

Family

ID=25264238

Family Applications (1)

Application Number Title Priority Date Filing Date
EP9393905020A Withdrawn EP0580846A4 (en) 1992-02-10 1993-02-08 Composite material having a lubricous surface for catheter use

Country Status (4)

Country Link
EP (1) EP0580846A4 (en)
JP (1) JPH06507106A (en)
CA (1) CA2108137A1 (en)
WO (1) WO1993015781A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996003163A1 (en) * 1994-07-25 1996-02-08 Advanced Cardiovascular Systems, Inc. Composite polyester material having a lubricous surface
US5505693A (en) * 1994-12-30 1996-04-09 Mackool; Richard J. Method and apparatus for reducing friction and heat generation by an ultrasonic device during surgery
US5599576A (en) * 1995-02-06 1997-02-04 Surface Solutions Laboratories, Inc. Medical apparatus with scratch-resistant coating and method of making same
CA2220121A1 (en) 1995-05-05 1996-11-07 Edwin Petrus Mahieu Intraluminal device with lubricious surface
US6217547B1 (en) 1996-01-16 2001-04-17 Advanced Cardiovascular Systems, Inc. Lubricous and readily bondable catheter shaft
DE69732836T2 (en) * 1996-01-16 2006-04-13 Advanced Cardiovascular Systems, Inc., Santa Clara SLITTING LIGHT-LIABLE CATHETER SHAFT
US5716322A (en) * 1996-03-13 1998-02-10 Johnson & Johnson Medical, Inc. Medical instrument and method for lubrication and sterilization thereof
CH690721A5 (en) * 1996-07-24 2000-12-29 Ct Io Trading Lda a low friction coefficient material and utilization of the material for the manufacture of skis and the like as well as a method of manufacturing a low friction coefficient material
US8383158B2 (en) * 2003-04-15 2013-02-26 Abbott Cardiovascular Systems Inc. Methods and compositions to treat myocardial conditions
US20060165926A1 (en) * 2005-01-27 2006-07-27 Jan Weber Medical devices including nanocomposites
US9539410B2 (en) 2005-04-19 2017-01-10 Abbott Cardiovascular Systems Inc. Methods and compositions for treating post-cardial infarction damage
US20080125745A1 (en) 2005-04-19 2008-05-29 Shubhayu Basu Methods and compositions for treating post-cardial infarction damage
JP5301438B2 (en) * 2006-07-28 2013-09-25 テイラー・メディカル・インコーポレイテッド Catheter components formed of a polymer compound containing particles or fibers
US9242005B1 (en) 2006-08-21 2016-01-26 Abbott Cardiovascular Systems Inc. Pro-healing agent formulation compositions, methods and treatments
US9005672B2 (en) 2006-11-17 2015-04-14 Abbott Cardiovascular Systems Inc. Methods of modifying myocardial infarction expansion
JP5331393B2 (en) * 2008-06-30 2013-10-30 オリンパス株式会社 Composite materials and medical tubing
EP3096805B1 (en) 2014-01-21 2023-11-29 Cardiac Pacemakers, Inc. Medical device hybrid polymeric structures and coatings with improved lubricity and durability

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0124757A2 (en) * 1983-04-09 1984-11-14 Licentia Patent-Verwaltungs-GmbH Method of lubricating mechanically actuated parts
JPS6037416A (en) * 1983-08-11 1985-02-26 Arai Pump Mfg Co Ltd Sliding material
US4668224A (en) * 1983-10-24 1987-05-26 Warner-Lambert Company Oxidized cellulose as a medical lubricant
EP0380102A1 (en) * 1989-01-26 1990-08-01 Advanced Cardiovascular Systems, Inc. Vascular catheter with durable lubricious coating
US5073365A (en) * 1989-06-01 1991-12-17 Advanced Polymer Systems Clinical and personal care articles enhanced by lubricants and adjuvants

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2855377A (en) * 1953-07-24 1958-10-07 Polymer Corp Polyamide articles incorporating molybdenum disulphide
US3287288A (en) * 1964-09-21 1966-11-22 Duriron Co Low friction composition containing a resinous binder and degraded polytetrafluoroethylene particles
US4100309A (en) * 1977-08-08 1978-07-11 Biosearch Medical Products, Inc. Coated substrate having a low coefficient of friction hydrophilic coating and a method of making the same
US4945126A (en) * 1983-02-14 1990-07-31 Ici Americas Inc. Methods of improving friction and wear properties of polymer systems
US4642267A (en) * 1985-05-06 1987-02-10 Hydromer, Inc. Hydrophilic polymer blend
US5135516A (en) * 1989-12-15 1992-08-04 Boston Scientific Corporation Lubricious antithrombogenic catheters, guidewires and coatings
US5084315A (en) * 1990-02-01 1992-01-28 Becton, Dickinson And Company Lubricious coatings, medical articles containing same and method for their preparation

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0124757A2 (en) * 1983-04-09 1984-11-14 Licentia Patent-Verwaltungs-GmbH Method of lubricating mechanically actuated parts
JPS6037416A (en) * 1983-08-11 1985-02-26 Arai Pump Mfg Co Ltd Sliding material
US4668224A (en) * 1983-10-24 1987-05-26 Warner-Lambert Company Oxidized cellulose as a medical lubricant
EP0380102A1 (en) * 1989-01-26 1990-08-01 Advanced Cardiovascular Systems, Inc. Vascular catheter with durable lubricious coating
US5073365A (en) * 1989-06-01 1991-12-17 Advanced Polymer Systems Clinical and personal care articles enhanced by lubricants and adjuvants

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
PATENT ABSTRACTS OF JAPAN vol. 9, no. 164 (M-395) 11 July 1985 & JP-A-60 037 416 (WASHIDA AKIRA ET AL.) 26 February 1985 *
See also references of WO9315781A1 *

Also Published As

Publication number Publication date
CA2108137A1 (en) 1993-08-11
JPH06507106A (en) 1994-08-11
EP0580846A4 (en) 1994-08-24
WO1993015781A1 (en) 1993-08-19

Similar Documents

Publication Publication Date Title
EP0773803A1 (en) Composite polyester material having a lubricous surface
US6277093B1 (en) Lubricious and readily bondable catheter shaft
EP0580846A1 (en) Composite material having a lubricous surface for catheter use
US5554121A (en) Intraluminal catheter with high strength proximal shaft
US6663614B1 (en) Catheter shaft having variable thickness layers and method of making
EP0540858B2 (en) Inflatable member having elastic expansion with limited range
US5290230A (en) Intraluminal catheter with a composite shaft
US6010521A (en) Catheter member with bondable layer
US5085649A (en) Torque controlled tubing
EP1663335B1 (en) Polymeric marker with high radiopacity for use in medical devices
EP0836861B1 (en) Catheter having nonlinear flow portion
CA2140782A1 (en) Balloon assembly with separately inflatable sections
CA2303159A1 (en) Polyether block amide catheter balloons
US7273487B1 (en) Balloon catheter having a multilayered shaft with variable flexibility
US6589464B1 (en) Lubricious catheter shaft
WO1994000176A1 (en) Composite material having a lubricous surface for catheter use
EP0652787A1 (en) Low profile catheter with expandable outer tubular member
EP1706165A1 (en) Medical devices
CA2243277A1 (en) Lubricous and readily bondable catheter shaft

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19931019

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched
AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 19960730

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19970211